company background image
XEJ

Accuray DB:XEJ Stock Report

Last Price

€2.21

Market Cap

€214.0m

7D

-4.5%

1Y

-28.2%

Updated

30 Jan, 2023

Data

Company Financials +

XEJ Stock Overview

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region.

XEJ fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance0/6
Financial Health4/6
Dividends0/6

My Notes

New

Notes are coming soon

Accuray Incorporated Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Accuray
Historical stock prices
Current Share PriceUS$2.21
52 Week HighUS$3.44
52 Week LowUS$1.66
Beta1.5
1 Month Change16.00%
3 Month Change8.65%
1 Year Change-28.21%
3 Year Change-40.24%
5 Year Change-51.93%
Change since IPO-89.38%

Recent News & Updates

Recent updates

Shareholder Returns

XEJDE Medical EquipmentDE Market
7D-4.5%1.3%1.2%
1Y-28.2%-15.3%-10.1%

Return vs Industry: XEJ underperformed the German Medical Equipment industry which returned -15.3% over the past year.

Return vs Market: XEJ underperformed the German Market which returned -10.1% over the past year.

Price Volatility

Is XEJ's price volatile compared to industry and market?
XEJ volatility
XEJ Average Weekly Movement6.0%
Medical Equipment Industry Average Movement4.8%
Market Average Movement5.1%
10% most volatile stocks in DE Market10.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: XEJ is not significantly more volatile than the rest of German stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: XEJ's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19901,044Suzanne Winterhttps://www.accuray.com

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day.

Accuray Incorporated Fundamentals Summary

How do Accuray's earnings and revenue compare to its market cap?
XEJ fundamental statistics
Market Cap€214.04m
Earnings (TTM)-€8.99m
Revenue (TTM)€385.57m

0.6x

P/S Ratio

-23.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
XEJ income statement (TTM)
RevenueUS$418.96m
Cost of RevenueUS$263.93m
Gross ProfitUS$155.03m
Other ExpensesUS$164.80m
Earnings-US$9.77m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

Feb 01, 2023

Earnings per share (EPS)-0.10
Gross Margin37.00%
Net Profit Margin-2.33%
Debt/Equity Ratio375.2%

How did XEJ perform over the long term?

See historical performance and comparison